Figure 1.
Figure 1. Vector design. (A) Skeletal muscle-directed gene transfer: The expression cassette contains the CMV enhancer/promoter, the simian virus 40 (SV40) polyadenylation signal, and is flanked by the AAV-2 inverted terminal repeats (ITRs). The human transgene contains cDNA of exon 1 from the human F.IX gene as WT or variants (K5A or K5A/V10K) interrupted by a 1.4-kb fragment of F.IX intron I, and exons 2 to 8 of the F.IX-WT or variant (R338A). The substitutions introduced in the mature F.IX sequence are indicated. (B) Liver-directed gene transfer: The expression cassette contains the human α1-antitrypsin promoter coupled to the human apolipoprotein E enhancer, exon 1 from the human F.IX gene, a truncated human F.IX intron 1, exons 2 to 8 of the F.IX gene WT or variant (R338A), and the bovine growth hormone polyadenylation signal sequence. The expression cassette is flanked by ITRs derived from AAV type 2.

Vector design. (A) Skeletal muscle-directed gene transfer: The expression cassette contains the CMV enhancer/promoter, the simian virus 40 (SV40) polyadenylation signal, and is flanked by the AAV-2 inverted terminal repeats (ITRs). The human transgene contains cDNA of exon 1 from the human F.IX gene as WT or variants (K5A or K5A/V10K) interrupted by a 1.4-kb fragment of F.IX intron I, and exons 2 to 8 of the F.IX-WT or variant (R338A). The substitutions introduced in the mature F.IX sequence are indicated. (B) Liver-directed gene transfer: The expression cassette contains the human α1-antitrypsin promoter coupled to the human apolipoprotein E enhancer, exon 1 from the human F.IX gene, a truncated human F.IX intron 1, exons 2 to 8 of the F.IX gene WT or variant (R338A), and the bovine growth hormone polyadenylation signal sequence. The expression cassette is flanked by ITRs derived from AAV type 2.

Close Modal

or Create an Account

Close Modal
Close Modal